21 – 30 of 178
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Building a precision medicine infrastructure at a national level: The Swedish experience
- Contribution to journal › Scientific review
-
Mark
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Novel precision medicine approaches and treatment strategies in hematological malignancies
- Contribution to journal › Scientific review
- 2022
-
Mark
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia
- Contribution to journal › Article
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
- Contribution to journal › Article
-
Mark
Implementing precision medicine in a regionally organized healthcare system in Sweden
- Contribution to journal › Letter
-
Mark
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)
- Contribution to journal › Article
-
Mark
Why B(-)other? About the gap of unknowns in ALL
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
- Contribution to journal › Article
-
Mark
High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
- Contribution to journal › Article
